NYSE · BFLY
Butterfly Network, Inc.
$7.51-$0.30 (-3.84%)
Butterfly Network, Inc.’s quoted price sits in the upper half of its reported 52-week range, 26.44% below the high.
Loading market information…
NYSE · EVH · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Evolent Health, Inc.’s quoted price sits in the lower half of its reported 52-week range, 40.14% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Evolent Health, Inc.’s next earnings report is currently expected on Nov 5, 2026, with estimated earnings per share of $0.06. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Evolent Health, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Evolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across the United States. Its operations are divided into two principal segments: Evolent Health Services and Clinical Solutions. The Evolent Health Services division delivers an integrated platform encompassing both administrative and clinical functions, specifically designed for health plan management and the oversight of population health. This includes essential financial and administrative support, such as managing health plan operations, risk assessment, robust analytics and reporting, and strategic leadership. A cornerstone of this segment is "Identifi," its proprietary technology, which intelligently aggregates and analyzes data, streamlines care workflows, and actively engages patients, all with the aim of achieving patient-centered and cost-effective population health outcomes. Conversely, the Clinical Solutions segment specializes in offering sophisticated care management services for various stakeholders involved in specialty care delivery. These services are crucial for organizations transitioning from traditional fee-for-service models to value-based care, accommodating their unique stage of development and prevailing market dynamics, particularly in the fields of oncology and cardiology. The overarching objective of this segment is a holistic improvement in the total cost of care. Founded in 2011, Evolent Health, Inc. maintains its corporate headquarters in Arlington, Virginia.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:39 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2025 | May 8, 2025 | $0.06-33.33% vs estimate | $483.65M+5.08% vs estimate |
|---|
| Q4 2024 | Feb 20, 2025 | -$0.02-105.26% vs estimate | $646.54M-0.67% vs estimate |
|---|
| Q3 2024 | Nov 7, 2024 | $0.04-86.67% vs estimate | $621.40M-4.72% vs estimate |
|---|
THE ANALYST VIEW
30 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 2 contributors · Median target $7.00.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$7.51-$0.30 (-3.84%)
Butterfly Network, Inc.’s quoted price sits in the upper half of its reported 52-week range, 26.44% below the high.
$46.94+$0.22 (+0.47%)
AMN Healthcare Services, Inc.’s quoted price sits in the upper half of its reported 52-week range, 5.4% below the high.
$15.93-$0.08 (-0.47%)
Personalis, Inc.’s quoted price sits in the upper half of its reported 52-week range, 15.7% below the high.
$17.39+$1.33 (+8.28%)
Replimune Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 2.19% below the high.
$210.10-$2.53 (-1.19%)
Nutex Health, Inc.’s quoted price sits in the upper half of its reported 52-week range, 7.1% below the high.
$33.80+$0.07 (+0.21%)
HealthStream, Inc.’s quoted price sits in the upper half of its reported 52-week range, 5.08% below the high.
$10.56-$0.16 (-1.49%)
Kura Oncology, Inc.’s quoted price sits in the lower half of its reported 52-week range, 24.03% below the high.
$9.71-$0.05 (-0.46%)
MeiraGTx Holdings plc’s quoted price sits in the lower half of its reported 52-week range, 36.78% below the high.
